Thomas A. Mitro

VP, Sales & Marketing, ISTA PHARMACEUTICALS INC.

Companies

Aerie PharmaceuticalsChief operating officer Oct 25, 2013 to Feb 9, 2022¹
Aerie PharmaceuticalsPresident Oct 25, 2013 to Feb 9, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aerie Pharmaceuticals AERI81,418 shares²Feb 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 8, 2022Shares withheld for tax 1,111 shares at $7.33 of Aerie Pharmaceuticals²
Feb 7, 2022Shares withheld for tax 1,310 shares at $7.24 of Aerie Pharmaceuticals²
Feb 6, 2022Shares withheld for tax 1,435 shares at $7.05 of Aerie Pharmaceuticals³
Feb 4, 2022Shares withheld for tax 1,435 shares at $7.05 of Aerie Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAerie Pharmaceuticals, Chief operating officer
2
SEC EDGARAerie Pharmaceuticals shares after the filing of Feb 8, 2022
3
SEC EDGARForm 4 filed Feb 8, 2022